Device Trial Radar · NCT03998137
Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft
Last checked: Nov 20, 2026Latest source record: Jul 9, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
94
Planned (sponsor's estimate)
Start
Aug 2019
Primary completion
Jun 2021
Study completion Jun 2021
Sponsor
- Lead sponsor
- BioMimetic TherapeuticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 26, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this long-term study is to evaluate the long-term effectiveness and safety of AUGMENT® Injectable Bone Graft vs. autologous bone graft. The study involves evaluation of subjects originally treated under protocol BMTI-2009-01 or BMTI-2010-01 or treated with autograft under protocol BMTI-2006-01. Subjects will be asked to consent and return to provide long-term follow-up data at or after 60 months (5 years) have elapsed since their original surgery as a subject in protocol BMTI-2009-01 or BMTI-2010-01. STUDY HYPOTHESIS: The effectiveness and safety profile for AUGMENT® Injectable Bone Graft is maintained and remains comparable to that of autologous bone graft over long-term subject follow-up. REGULATORY PHASE: Post-approval study
Conditions
- Ankle and Hindfoot Arthrodesis
Interventions
AUGMENT® Injectable Bone GraftDevice
AUGMENT® Injectable Bone Graft
Standard of CareProcedure
Autologous Bone Graft
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain on weight bearing via Visual Analog Scale (VAS)Time frame: Visit 1 (Day 0)
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.